PW Medtech repurchases shares, utilizing current mandate

PW Medtech Group Limited submitted its Next Day Disclosure Return on September 23, 2025, detailing recent share repurchase activities. On September 23, 2025, the company repurchased 63,000 ordinary shares on the Exchange at a price of HK$1.55 per share, totaling HK$97,650. These shares are intended for cancellation.

Including this latest transaction, the total number of shares repurchased for cancellation but not yet cancelled, as of September 23, 2025, amounts to 8,246,000 shares across multiple transactions since September 1, 2025. The repurchases have been made at prices ranging from HK$1.392 to HK$1.55 per share.

The company's current repurchase mandate, authorized on June 10, 2025, permits the repurchase of up to 148,673,509 shares. As of the mandate date, 13,209,000 shares, representing 0.8885% of the issued shares, have been repurchased. A moratorium period for new share issues or sales of treasury shares after repurchases is set until October 23, 2025.